Sarah Snelling

Sarah Snelling is an Associate Professor and Senior Scientific Officer at the NIHR Biomedical Research Centre Musculoskeletal theme within the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) at the University of Oxford. She leads the Soft Tissue Repair Group and holds a lectureship in Biomedicine at St Hilda's College, Oxford, where she contributes to undergraduate teaching.

Her educational background includes an MBiochem in Biochemistry from the University of Oxford, followed by a DPhil in the genetics and functionality of osteoarthritis conducted at the Botnar Institute within NDORMS. This foundational training established her expertise in musculoskeletal tissue biology.

Snelling's research program centers on applying next-generation sequencing to characterize cellular and molecular signatures of healthy and diseased musculoskeletal tissues, with particular focus on tendon, ligament, and bone. Her work identifies key cell types and molecules driving tissue health and disease progression, addressing critical unmet clinical needs in tissue repair where surgical interventions often fail. Her group studies tendinopathies, ligament disease, joint infection, osteoarthritis, and fracture mechanisms to develop pharmacologic and surgical treatment strategies.

Analysis of her recent publications reveals a dominant emphasis on single-cell and spatial genomics to map the musculoskeletal system, resulting in tissue atlases that inform treatment evaluation. Key thematic trends include tendon repair mechanisms (evident in her 2024-2025 quadriceps tendon studies), osteoarthritis pathophysiology (2021 IL-17A research), and global implementation of genomic technologies (2024 LMIC barriers paper), all converging toward clinical translation.

She leads several major collaborative initiatives including the CZI Tendon Seed Network, the Ancestrally Inclusive Musculoskeletal Single-Cell Network, and serves as the Musculoskeletal Biological Network coordinator for the Human Cell Atlas, demonstrating her leadership in large-scale international research consortia.